Concurrent Session 2A: Abstract Session. Progress Towards HCV Elimination
Tracks
.
| Wednesday, October 7, 2026 |
| 4:00 PM - 5:30 PM |
| Zenit |
Speaker
INHSU 2026
Welcome & Introduction
4:00 PM - 4:05 PMBiography
Ms Farzaneh Vakili
Ph.D. Student
Université de Montréal
Changes in housing status and HCV incidence among people who inject drugs in Montreal, Canada: longitudinal cohort study, 2011-2024
4:05 PM - 4:20 PMBiography
Farzaneh Vakili is a PhD student in Biomedical Sciences at the University of Montreal under the supervision of Dr. Julie Bruneau and Dr. Sarah Larney. Her research broadly concentrates on the social determinants of health among people who inject drugs and blood-borne viral infections among this population.
Dr Abdelmajid Djennad
Statistician
Uk Health Security Agency
Declining hepatitis C prevalence in people who inject drugs: synthesising multiple sources of surveillance data
4:20 PM - 4:35 PMBiography
PhD on time series with work experience on environmental health, Campylobacter and weather, vaccine effectiveness and impact against invasive pneumococcal disease and prevalence estimation of opiate and crack cocaine use and injecting.
Professor Sharon Hutchinson
Professor Of Epidemiology And Population Health
Glasgow Caledonian University
Mortality ten years before and after the introduction of direct acting antivirals for people in Scotland with hepatitis C infection: a population cohort study
4:35 PM - 4:50 PMBiography
Sharon Hutchinson is a Professor of Epidemiology and Population Health at Glasgow Caledonian University and Honorary Consultant with Public Health Scotland. Her research focusses on the evaluation of interventions to prevent blood-borne viruses and related harms among people who inject drugs. Her work has particularly helped to inform and evaluate Scotland’s elimination strategy on Hepatitis C. With UK partners, she co-led the NIHR research project “Evaluating the Population Impact of hepatitis C direct-acting antiviral Treatment as prevention for People who inject drugs” (EPIToPe).
Dr Behzad Hajarizadeh
Associate Professor
Unsw/ Kirby Institute
The incidence of hepatitis C virus infection among people who inject drugs in Australia: the ETHOS Engage study
4:50 PM - 5:05 PMBiography
Associate Professor Behzad Hajarizadeh is a clinical epidemiologist in the Kirby Institute, University of New South Wales. His main areas of research include epidemiology and clinical management of viral hepatitis, particularly in prison, and among people who inject drugs.
Dr Sarah Larney
Professor
Burnet Institute
Simulating epidemics: the performativity of systematic review methods
5:05 PM - 5:10 PMBiography
Sarah Larney is a Professor at the Burnet Institute, Melbourne, Australia. She primarily works on the epidemiology and prevention of drug-related harms including overdose, hepatitis C and HIV, but is also engaged with critical social sciences scholarship aiming to problematise current epidemiological methods.
Mrs Anahit Sharafyan
Head Of The Infectious Disease Department
Penitentiary Medical Center
We did it: HCV microelimination in penitentiary institutions of Armeia
5:10 PM - 5:15 PMBiography
I graduated from Yerevan State Medical University in 1988. I have about 35 years of medical work experience now. For the last 15 years, I have been working at the Penitentiary Medical Centre as an Infectious Diseases Doctor. Since 2019, I have been the Head of the Infectious Diseases Department.
Professor Mark Stoové
Head of Public Health, Head of Justice Health Research
Burnet Institute
Dr Sofia Bartlett
Scientific director, Clinical Prevention Services
BC Centre for Disease Control
Peer-led pop-up clinics improve hepatitis C care cascade outcomes for people at-risk for or released from incarceration in British Columbia, Canada
5:20 PM - 5:25 PMBiography
Sofia Bartlett obtained a PhD from the University of New South Wales in Sydney, Australia and completed postdoctoral training at the University of British Columbia, gaining multidisciplinary expertise spanning basic science, infectious disease epidemiology, and public health practice. Her work prioritizes community-based and participatory research approaches that maximize the potential for policy and program impact, while advancing the rights and dignity of people impacted by sexually transmitted and blood-borne infections.
INHSU 2026
Session Q&A
5:25 PM - 5:30 PMBiography